CSRP3 — a cysteine-rich protein previously linked to cardiomyopathy — proves essential for skeletal muscle satellite cell (SC) differentiation in pigs but dispensable in mice. Knockdown of CSRP3 in porcine SCs impaired myogenic differentiation and reduced regenerative capacity in injury models, while overexpression enhanced both. Mechanistically, CSRP3 deficiency disrupted AKT-SERCA2 signaling, elevating intracellular calcium, triggering mitochondrial dysfunction, and accelerating MYOG protein degradation. Pharmacological AKT activation rescued differentiation in CSRP3-deficient porcine cells. Csrp3-knockout mice, by contrast, showed normal SC function and intact AKT-SERCA2 activity.
This species divergence is the study's most consequential finding — and its most cautionary one. The mouse has served as the default model for muscle regeneration research for decades, yet this work demonstrates that a mechanistically important regulator operates differently across species. The porcine-human physiological similarity in muscle mass, fiber-type composition, and aging trajectories makes these findings potentially more translatable than most rodent studies.
For regenerative medicine, the implications are tangible: engineered porcine SCs with enhanced CSRP3 activity could improve xenotransplantation outcomes for muscular dystrophies or sarcopenia. However, this remains preclinical work with no human validation, and the calcium-mitochondrial axis identified here requires further dissection before therapeutic targeting. The AKT-SERCA2 connection adds mechanistic depth to calcium homeostasis in myogenesis, an underexplored area. Overall, this is an incremental but directionally important finding that reframes model-organism assumptions in muscle stem cell biology.
